MedTrace Logo

A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania

NCT02382107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-03-07

No results posted yet for this study

Summary

The diagnosis of tuberculosis (TB) and especially the detection of drug resistance of tuberculosis mycobacteria can be time consuming and costly. New and rapid diagnostic tests are needed to improve early case detection and correct initiation of treatment.

In the planned cross-sectional diagnostic evaluation study the investigators are aiming for the assessment of several new TB diagnostics (e.g. new AID strip assays and TrDNA assay in urine) in TB suspects who are presenting themselves to the pulmonary ambulance (TB dispensary for sector 4) at the Marius Nasta Institute (MNI). The study will be conducted in a co-operation between the MNI and the German Center for Infection Research (DZIF).

Conditions

Interventions

OTHER

Observational

TB suspects, who present themselves to the pulmonary ambulance at the Marius Nasta Instiute

Sponsors & Collaborators

  • "Marius Nasta" Pulmonology Institute

    collaborator OTHER

  • Clinical Infectious Diseases Research Center Borstel, Germany

    collaborator UNKNOWN

  • Michael Hoelscher

    lead OTHER

Principal Investigators

  • Elmira Ibraim, MD · Marius Nasta Pulmonology Institute, Sos. Viilor 90 Sector 5, 050159 Bucharest, Romania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-05-31
Completion
2017-08-31

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02382107 on ClinicalTrials.gov